Hep C Discussion Forum

Members Login
Username 
 
Password 
    Remember Me  
Chatbox
Please log in to join the chat!
Hep C Discussion Forum -> Hep C News -> NICE (UK) announce criteria for access to Daklinza, Harvoni, Viekirax and Exviera
Post Info TOPIC: NICE (UK) announce criteria for access to Daklinza, Harvoni, Viekirax and Exviera
Cinnamon Girl


Guru

Status: Offline
Posts: 5629
Date:
NICE (UK) announce criteria for access to Daklinza, Harvoni, Viekirax and Exviera
Permalink  
 

Very good news for Hep C patients in the UK with Gen 1 and 4, and some with Gen 3!

The National Institute of Clinical Excellence (NICE) have announced which of the new treatments would be made available by the NHS to people living with hepatitis C.  This NICE decision is concerned with widening access beyond patients who were given access to new treatments earlier this year under the Early Access Scheme for those with decompensated cirrhosis.

The new treatments under consideration are:

  • Harvoni, a combination of two drugs, ledipasvir and sofosbuvir.  It is produced by Gilead

  • Daklinza, a combination of two drugs, daclatasvir and sofosbuvir.  Daclatasvir produced by Bristol Myers Squibb and sofosbuvir by Gilead.

  • Viekirax, is a combination of four drugs, ombitasvir, paritaprevir, ritonavir and Exviera (dasabuvir).  They are produced by AbbVie.

All those with genotypes 1 and 4, should now be able to access the new non-interferon based treatments with shorter treatment times and less severe side effects.

Some people living with genotype 3, can access Daklinza.  None of the treatments looked at by NICE at this stage are for genotype 2, there are trials taking place for new treatments for this genotype.

Full details of treatment criteria, by genotype...

http://www.hepctrust.org.uk/news/oct-2015/nice-announce-criteria-access-daklinza-harvoni-viekirax-and-exviera



__________________

Jill 

(71 yo, lives in UK)

Was Gen 3a, 

24wks Peg Ifn/Riba, Sep 2010 - Mch 2011

UND @ Wk.4, UND @ EOT, 

SVR Nov 2011 --> Still UND @ EOT + 4 yrs.

 

 
Page 1 of 1  sorted by
 
Quick Reply

Please log in to post quick replies.
Hep C Discussion Forum -> Hep C News -> NICE (UK) announce criteria for access to Daklinza, Harvoni, Viekirax and Exviera
Legal Disclaimer:

THIS FORUM, IT'S OWNERS, ADMINISTRATORS, MODERATORS AND MEMBERS DO NOT AT ANY TIME GIVE MEDICAL ADVICE AND IN ALL CASES REFER ANYONE HERE TO SEEK APPROPRIATE MEDICAL ADVICE FROM THEIR DOCTOR.